Company Filing History:
3 out of 12 
3 out of 97 
Years Active: 2017-2021
Title: Innovations of Omar Quintero-Monzon: A Focus on TDP-43 Binding Molecules
Introduction
Omar Quintero-Monzon is an acclaimed inventor based in Waltham, MA, recognized for his significant contributions to biotechnology. With a portfolio that includes three patents, Quintero-Monzon has been actively involved in the development of innovative solutions aimed at addressing critical issues in the field of neuroscience.
Latest Patents
Among his most notable patents are those related to TDP-43 specific binding molecules. These innovations encompass TAR DNA-binding protein of 43 kDa (TDP-43)-specific binding molecules, which include human antibodies, fragments, derivatives, and variants thereof. The patents also detail methods associated with these TDP-43 specific binding molecules, including assays, kits, and solid supports that utilize polypeptides such as human antibodies. The TDP-43-specific binding molecules have potential applications in pharmaceutical and diagnostic compositions, particularly for TDP-43 targeted immunotherapy and diagnosis.
Career Highlights
Quintero-Monzon has gained substantial experience by working with leading organizations in the field, including Biogen International Neuroscience GmbH and the University of Zürich. His work has been instrumental in proposing practical approaches to tackle challenging neurological disorders.
Collaborations
Throughout his career, Quintero-Monzon has collaborated with notable experts such as Roger Nitsch and Christoph Hock. These partnerships highlight the synergistic nature of scientific research, where collaborative efforts lead to groundbreaking advancements in biotechnology.
Conclusion
Omar Quintero-Monzon's contributions to innovation, particularly in the realm of TDP-43 specific binding molecules, underscore the importance of research and development in addressing neurological health challenges. His ongoing work and collaborations are likely to pave the way for further breakthroughs in immunotherapy and diagnostics, enhancing our understanding and treatment of complex diseases.